138 related articles for article (PubMed ID: 2997819)
21. The effects of thyrotropin-releasing hormone, metabolites and analogues on locomotor activity in rats.
Andrews JS; Sahgal A
Regul Pept; 1983 Oct; 7(2):97-109. PubMed ID: 6658017
[TBL] [Abstract][Full Text] [Related]
22. Estradiol, TRH and striatal dopaminergic mechanisms.
Bédard PJ; Malouin F; Dipaolo T; Labrie F
Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):555-61. PubMed ID: 6819600
[TBL] [Abstract][Full Text] [Related]
23. Repeated administration of triiodothyronine (T3) to rats enhances nigrostriatal and mesolimbic dopaminergic behavioural responses.
Heal DJ; Atterwill CK
Neuropharmacology; 1982 Feb; 21(2):159-62. PubMed ID: 7063110
[TBL] [Abstract][Full Text] [Related]
24. A comparison of the locomotor effects induced by centrally injected TRH and TRH analogues.
Sharp T; Bennett GW; Marsden CA; Tulloch IF
Regul Pept; 1984 Nov; 9(4):305-15. PubMed ID: 6441196
[TBL] [Abstract][Full Text] [Related]
25. Thyrotropin-releasing hormone: hyperactivity and mesolimbic dopamine system in rats.
Miyamoto M; Narumi S; Nagai Y; Shima T; Nagawa Y
Jpn J Pharmacol; 1979 Jun; 29(3):335-47. PubMed ID: 119887
[TBL] [Abstract][Full Text] [Related]
26. [Effects of injecting 6-hydroxydopamine into areas of the nigro-striatal (A9) and mesolimbic (A10) dopaminergic systems on the elaboration of a conditioned feeding reflex in the rat].
Zhukova EM; Spiridonov VK; Loskutova LV
Zh Vyssh Nerv Deiat Im I P Pavlova; 1987; 37(1):88-94. PubMed ID: 3107237
[TBL] [Abstract][Full Text] [Related]
27. Different interactions of prolyl oligopeptidase and neurotensin in dopaminergic function of the rat nigrostriatal and mesolimbic pathways.
Peltonen I; Myöhänen TT; Männistö PT
Neurochem Res; 2012 Sep; 37(9):2033-41. PubMed ID: 22729983
[TBL] [Abstract][Full Text] [Related]
28. Lesions of the superior colliculus in the rat differentiate between nigrostriatal and mesolimbic dopamine systems.
Dawbarn D; Pycock CJ
Brain Res; 1982 Mar; 235(1):148-55. PubMed ID: 6892367
[TBL] [Abstract][Full Text] [Related]
29. The effects of chronic ethanol consumption on the mesolimbic and nigrostriatal dopamine systems.
Pellegrino SM; Druse MJ
Alcohol Clin Exp Res; 1992 Apr; 16(2):275-80. PubMed ID: 1534209
[TBL] [Abstract][Full Text] [Related]
30. Effects of chronic ethanol consumption on G proteins in brain areas associated with the nigrostriatal and mesolimbic dopamine systems.
Pellegrino SM; Woods JM; Druse MJ
Alcohol Clin Exp Res; 1993 Dec; 17(6):1247-53. PubMed ID: 8116839
[TBL] [Abstract][Full Text] [Related]
31. Influence of thyrotropin releasing hormone and histidyl-proline diketopiperazine on spontaneous locomotor activity and analgesia induced by delta 9-tetrahydrocannabinol in the mouse.
Bhargava HN; Matwyshyn GA
Eur J Pharmacol; 1980 Nov; 68(2):147-54. PubMed ID: 6258926
[TBL] [Abstract][Full Text] [Related]
32. Behavioral and biochemical effects of amperozide and serotonin agents on nigrostriatal and mesolimbic dopamine systems.
Chang PY; Chuang CH; Chen JC; Tung CS
Chin J Physiol; 2008 Apr; 51(2):106-15. PubMed ID: 18666714
[TBL] [Abstract][Full Text] [Related]
33. Thyrotropin releasing hormone but not histidyl-proline diketopiperazine is depleted from rat spinal cord following 5,7-dihydroxytryptamine treatment.
Lechan RM; Jackson IM
Brain Res; 1985 Feb; 326(1):152-5. PubMed ID: 3918765
[TBL] [Abstract][Full Text] [Related]
34. Thyrotropin-releasing hormone (TRH) content of rat striatum: modification by drugs and lesions.
Spindel ER; Pettibone DJ; Wurtman RJ
Brain Res; 1981 Jul; 216(2):323-31. PubMed ID: 6265032
[TBL] [Abstract][Full Text] [Related]
35. Dissociation between circling behaviour and striatal dopamine activity following unilateral deltamethrin administration to rats.
Brodie ME; Opacka J
Naunyn Schmiedebergs Arch Pharmacol; 1985 Dec; 331(4):341-6. PubMed ID: 2419769
[TBL] [Abstract][Full Text] [Related]
36. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats.
Hudson JL; van Horne CG; Strömberg I; Brock S; Clayton J; Masserano J; Hoffer BJ; Gerhardt GA
Brain Res; 1993 Oct; 626(1-2):167-74. PubMed ID: 8281427
[TBL] [Abstract][Full Text] [Related]
37. Re-evaluation of histidyl-proline diketopiperazine [cyclo(His-Pro)] effects on food intake in the rat.
Bowden CR; Karkanias CD; Bean AJ
Pharmacol Biochem Behav; 1988 Feb; 29(2):357-63. PubMed ID: 3129742
[TBL] [Abstract][Full Text] [Related]
38. Dopamine-like action of nicotine: lack of tolerance and reverse tolerance.
Lapin EP; Maker HS; Sershen H; Hurd Y; Lajtha A
Brain Res; 1987 Mar; 407(2):351-63. PubMed ID: 3567650
[TBL] [Abstract][Full Text] [Related]
39. The effects of some polyamines on putative behavioural indices of mesolimbic versus striatal dopaminergic function.
Hirsch SR; Richardson-Andrews R; Costall B; Kelly ME; de Belleroche J; Naylor RJ
Psychopharmacology (Berl); 1987; 93(1):101-4. PubMed ID: 2819921
[TBL] [Abstract][Full Text] [Related]
40. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
